NCT05296941 (PMOD) is a NA clinical trial of Brush sampling in Mouth Neoplasms, sponsored by Dalarna County Council, Sweden.

Who is sponsoring NCT05296941?

NCT05296941 is sponsored by Dalarna County Council, Sweden.

What drugs are being tested in NCT05296941?

Interventions in NCT05296941: Brush sampling.

What condition does NCT05296941 study?

NCT05296941 studies Mouth Neoplasms.

Is NCT05296941 still recruiting?

NCT05296941 is currently recruiting now. Last updated 8 September 2023.

Last reviewed 2023-09-08 · How we verify

NCT05296941: PMOD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Oral Cancer Screening for Early Detection of Premalignant Disorders (PMOD)

Recruiting now NA Last updated 8 September 2023

What this trial tests

NA trial testing Brush sampling in Mouth Neoplasms in 200 participants. Currently enrolling.

Timeline

1 August 2023

Primary endpoint
31 December 2029

31 December 2029

Quick facts

Lead sponsor	Dalarna County Council, Sweden
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	200
Start date	1 August 2023
Primary completion	31 December 2029
Estimated completion	31 December 2029
Sites	1 location across Sweden

Drugs / interventions tested

Brush sampling

Conditions studied

Mouth Neoplasms — all drugs for Mouth Neoplasms →

Sponsor

Dalarna County Council, Sweden

Who can join

18 and older, any sex, with Mouth Neoplasms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cancer is a complex disease; its different causes and types have a strong impact on patient treatment and prognosis. To improve understanding of the disease, its causes and progression, the investigators will develop a simple, cost-effective system for continuous control of mucosal lesions with non-invasive brush biopsy that can be managed in primary dental care, as an alternative to tissue biopsy in order to reduce the number of oral cavity cancers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Mouth Neoplasms

Currently open trials in the same condition.

NCT07401641 — Effect of Dezocine Versus Nalbuphine Combined With Sufentanil on Postoperative Analgesia, Complications, and Free Flap S · NA · recruiting

Other Dalarna County Council, Sweden trials

Trials by the same sponsor.

NCT07586033 — Prevalence and Functional Impact of Hand and Wrist Symptoms in Ice Hockey Players · not yet recruiting
NCT07115160 — The Leksand Hockey Trial on Grip Strength · NA · recruiting
NCT06984120 — Increased Extravascular Lung Water in Asymptomatic Open-water Swimmers · completed
NCT05923762 — Oral Health Related Quality of Life · unknown
NCT07031869 — The Swedish Hockey League Hand and Wrist Injury Tracking Trial · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05296941 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dalarna County Council, Sweden
Last refreshed: 8 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05296941.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing